Baudax Historical Income Statement

BXRX Stock  USD 0.01  0.0009  7.83%   
Historical analysis of Baudax BioInc income statement accounts such as Interest Expense of 25.4 M, Selling General Administrative of 22.7 M or Total Revenue of 1.5 M can show how well Baudax BioInc performed in making a profits. Evaluating Baudax BioInc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Baudax BioInc's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Baudax BioInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Baudax BioInc is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.

About Baudax Income Statement Analysis

Baudax BioInc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Baudax BioInc shareholders. The income statement also shows Baudax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Baudax BioInc Income Statement Chart

Baudax BioInc Income Statement is one of the three primary financial statements used for reporting Baudax's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Baudax BioInc revenue and expense. Baudax BioInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Baudax BioInc's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 25.4 M in 2024, whereas Operating Income is likely to drop (36.8 M) in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Baudax BioInc. It is also known as Baudax BioInc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Baudax BioInc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Baudax BioInc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.At this time, Baudax BioInc's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 25.4 M in 2024, whereas Operating Income is likely to drop (36.8 M) in 2024.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation2.8M2.2M2.3M1.7M
Total Operating Expenses51.0M30.0M36.3M38.0M

Baudax BioInc income statement Correlations

-0.32-0.6-0.05-0.51-0.71-0.420.79-0.630.43-0.51-0.520.20.78-0.5-0.850.76-0.69-0.69
-0.320.580.230.33-0.13-0.41-0.630.510.570.330.560.1-0.56-0.140.3-0.260.10.1
-0.60.58-0.43-0.13-0.010.44-0.830.96-0.22-0.130.44-0.54-0.680.520.75-0.760.490.49
-0.050.23-0.430.850.41-0.60.14-0.420.480.85-0.010.930.03-0.68-0.360.39-0.44-0.44
-0.510.33-0.130.850.67-0.4-0.21-0.150.261.00.390.62-0.33-0.410.050.020.070.07
-0.71-0.13-0.010.410.670.3-0.150.07-0.430.670.010.19-0.170.120.44-0.370.30.3
-0.42-0.410.44-0.6-0.40.3-0.30.56-0.95-0.4-0.25-0.56-0.20.840.65-0.670.360.36
0.79-0.63-0.830.14-0.21-0.15-0.3-0.830.18-0.21-0.640.270.96-0.55-0.790.73-0.56-0.56
-0.630.510.96-0.42-0.150.070.56-0.83-0.33-0.150.28-0.49-0.670.630.82-0.770.470.47
0.430.57-0.220.480.26-0.43-0.950.18-0.330.260.250.470.15-0.79-0.580.61-0.36-0.36
-0.510.33-0.130.851.00.67-0.4-0.21-0.150.260.390.62-0.33-0.410.050.020.070.07
-0.520.560.44-0.010.390.01-0.25-0.640.280.250.39-0.25-0.720.030.32-0.270.650.65
0.20.1-0.540.930.620.19-0.560.27-0.490.470.62-0.250.17-0.65-0.520.51-0.69-0.69
0.78-0.56-0.680.03-0.33-0.17-0.20.96-0.670.15-0.33-0.720.17-0.47-0.680.62-0.57-0.57
-0.5-0.140.52-0.68-0.410.120.84-0.550.63-0.79-0.410.03-0.65-0.470.8-0.770.540.54
-0.850.30.75-0.360.050.440.65-0.790.82-0.580.050.32-0.52-0.680.8-0.940.670.67
0.76-0.26-0.760.390.02-0.37-0.670.73-0.770.610.02-0.270.510.62-0.77-0.94-0.5-0.5
-0.690.10.49-0.440.070.30.36-0.560.47-0.360.070.65-0.69-0.570.540.67-0.51.0
-0.690.10.49-0.440.070.30.36-0.560.47-0.360.070.65-0.69-0.570.540.67-0.51.0
Click cells to compare fundamentals

Baudax BioInc Account Relationship Matchups

Baudax BioInc income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization(28.6M)21.6M(29.3M)44.1M50.8M53.3M
Selling General Administrative27.0M43.3M45.3M14.7M19.0M22.7M
Total Revenue349K493K1.1M1.3M1.5M1.5M
Other Operating Expenses47.1M56.3M53.5M37.0M33.3M41.0M
Operating Income(32.5M)(74.8M)(19.0M)(56.8M)(35.0M)(36.8M)
Net Income From Continuing Ops(32.6M)(76.1M)(19.8M)(58.8M)(58.7M)(61.7M)
Ebit(32.5M)(74.8M)(19.0M)(56.8M)(51.1M)(53.7M)
Research Development20.1M9.1M3.1M3.9M8.3M12.4M
Ebitda(61.1M)(53.2M)(48.3M)(12.7M)(14.6M)(15.3M)
Total Operating Expenses47.1M54.6M51.0M30.0M36.3M38.0M
Reconciled Depreciation480K2.6M2.8M2.2M2.3M1.7M
Income Before Tax(32.6M)(76.1M)(19.8M)(58.8M)(58.7M)(61.7M)
Total Other Income Expense Net(38K)(1.3M)(763K)(2.0M)(23.7M)(22.5M)
Net Income Applicable To Common Shares(32.6M)(76.1M)(17.3M)(58.8M)(67.6M)(71.0M)
Net Income(18.0M)(76.1M)(19.8M)(58.8M)(7.2M)(7.5M)
Income Tax Expense(14.6M)1.4M3.8M23.1M26.5M27.8M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Baudax BioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Baudax BioInc's short interest history, or implied volatility extrapolated from Baudax BioInc options trading.

Pair Trading with Baudax BioInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.

Moving against Baudax Stock

  0.81NUVB Nuvation Bio Financial Report 2nd of May 2024 PairCorr
  0.64IMMP Immutep Ltd ADRPairCorr
  0.61IOVA Iovance Biotherapeutics Financial Report 14th of May 2024 PairCorr
  0.59ZNTL Zentalis PharmaceuticalsL Financial Report 8th of May 2024 PairCorr
  0.5MRSN Mersana Therapeutics Downward RallyPairCorr
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(94.13)
Revenue Per Share
0.318
Quarterly Revenue Growth
(0.23)
Return On Assets
(1.15)
Return On Equity
(47.04)
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.